Financhill
Back

Aldeyra Therapeutics Stock Predictions

Aldeyra Therapeutics Stock Forecast

  • Is Aldeyra Therapeutics Stock Undervalued?
    The current Aldeyra Therapeutics [ALDX] share price is $4.21. The Score for ALDX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ALDX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Aldeyra Therapeutics Stock Go Up Next Year?

Data Unavailable

Aldeyra Therapeutics Stock Rating

Data Unavailable

Aldeyra Therapeutics Stock Price History

Is ALDX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALDX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aldeyra.com

52-Week Data

52-Week High:
6.55
52-Week Low:
2.43

Prediction Charts

Market Cap:
250.7M
Price in USD:
4.21
Volume:
621.08K
Beta:
1.24

Technical Analysis

SMA50:
5.46
SMA100:
4.89
SMA200:
4.29
52-Wk Change:
67.06%

Stock Predictions

  • Is Aldeyra Therapeutics stock public?
    Yes, Aldeyra Therapeutics is a publicly traded company.
  • What is the Aldeyra Therapeutics stock quote today?
    The Aldeyra Therapeutics stock price is 4.21 USD today.
  • How to buy Aldeyra Therapeutics stock online?
    You can buy Aldeyra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-29 5.67 5.42 5.72 5.37
Oct-30 5.38 5.33 5.52 5.31
Oct-31 5.31 5.25 5.34 5.16
Nov-1 5.29 5.36 5.38 5.21
Nov-4 5.34 5.17 5.39 5.09
Nov-5 5.12 5.27 5.28 4.93
Nov-6 5.54 5.40 5.74 5.24
Nov-7 5.39 5.33 5.50 5.24
Nov-8 5.37 5.52 5.58 5.25
Nov-11 5.55 5.49 5.64 5.43
Nov-12 5.42 4.76 5.42 4.57
Nov-13 4.83 4.41 4.83 4.38
Nov-14 4.42 4.27 4.51 4.16
Nov-15 4.29 4.21 4.33 4.09

Aldeyra Therapeutics Earnings

Data Unavailable

Aldeyra Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.14 per share.

* Aldeyra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.